Skip to content
HeyJared

San Francisco

Reporter · US

Indexed articles, last 90 days
3
Latest publication
Aug 31, 2026
Outlet visibility, for Newswise
Top 1M sites
Earliest in this view
Aug 3, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Aug 31, 2026 · by University of California, San Francisco (UCSF)

    UCSF-Led Group Receives $9 Million for Inflammatory Heart Disease Research | Newswise (opens the original)

    Excerpt · English

    Read excerpt

    Javid Moslehi, MD, William Grossman Distinguished Professor in Cardiology and chief of the UCSF Section of Cardio-Oncology and Immunology, and CoeurTCR Network, North American lead. Javid Moslehi, MD, and Josiah Gerdts, MD, PhD, with members of the Moslehi and Gerdts Lab at UCSF. Newswise — An international research network led in North America by UC San Francisco (UCSF) has received a $9 million award from the Leducq Foundation, a cardiovascular research funding organization, to uncover how the

  2. Article · Aug 10, 2026 · by University of California, San Francisco (UCSF)

    Can Mini Organs Help Predict Breast Tumors’ Response to Therapy? | Newswise (opens the original)

    Excerpt · English

    Read excerpt

    Senior study author Jennifer Rosenbluth, MD, PhD, (right) and study first author Tam Binh Bui, MSc, MD (left) working together in the Rosenbluth Lab at UCSF. Newswise — Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from the I-SPY2 breast cancer trial and rapid testing on lab-grown mini tumors. The advance could hasten more personalized treatments for breast cancer, including the triple neg

  3. Article · Aug 3, 2026 · by University of California, San Francisco (UCSF)

    UCSF Cancer Researcher Awarded Prize for Early Career Scientists | Newswise (opens the original)

    Excerpt · Positive tone · English

    Read excerpt

    Adam Blaisdell, MD, PhD, UCSF physician-scientist and CRI IGNITE fellow. Newswise — UCSF Health’s Adam Blaisdell, MD, PhD, has been selected as an IGNITE fellow by the Cancer Research Institute (CRI), a New York-based nonprofit that funds and promotes cancer immunotherapy research. The IGNITE Award — Inspiring Growth and Nurturing Independence Through Excellence — is a new initiative designed to provide funding for early-career scientists whose research is focused on cancer immunology and immuno

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 1M sites

For Newswise, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about San Francisco